Correlation Between Neuropace and Sientra

Can any of the company-specific risk be diversified away by investing in both Neuropace and Sientra at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Sientra into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neuropace and Sientra, you can compare the effects of market volatilities on Neuropace and Sientra and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Sientra. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Sientra.

Diversification Opportunities for Neuropace and Sientra

0.88

Correlation Coefficient

Neuropace  Sientra

Very poor diversification

The 3 months correlation between Neuropace and Sientra is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Sientra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sientra and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Sientra. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sientra has no effect on the direction of Neuropace i.e., Neuropace and Sientra go up and down completely randomly.

Pair Corralation between Neuropace and Sientra

If you would invest  1,066  in Neuropace on September 26, 2024 and sell it today you would earn a total of  48.00  from holding Neuropace or generate 4.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	4.76%
Values	Daily Returns

Neuropace  vs.  Sientra

Neuropace

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Sientra

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sientra has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Sientra is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Neuropace and Sientra

The main advantage of trading using opposite Neuropace and Sientra positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Sientra can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sientra will offset losses from the drop in Sientra's long position.

The idea behind Neuropace and Sientra pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.